Identification of Genetic Variants Influencing Efficacy of Lisinopril Treatment on Age-specific Physical Performance: A Genome-wide Analysis in Drosophila melanogaster

dc.contributor.advisorLeips, Jeff
dc.contributor.advisorAbadir, Peter
dc.contributor.authorGabrawy, Mariann
dc.contributor.departmentBiological Sciences
dc.contributor.programBiological Sciences
dc.date.accessioned2021-01-29T18:13:48Z
dc.date.available2021-01-29T18:13:48Z
dc.date.issued2018-01-01
dc.description.abstractAge-related decline in physical performance is a general phenomenon in most organisms and in humans confers high risk for disability and mortality. Despite the near ubiquity of senescence and extensive variation among individuals in age-related decline in physical performance, we know little about the genes responsible for this variation. In humans, alterations in the Renin-Angiotensin System (RAS) have been implicated in the pathogenesis of late life physical decline. Pharmacological blockade of RAS, such as that by angiotensin-converting enzyme inhibitor Lisinopril, has been proposed as a treatment to attenuate such age-related declines. Some studies have shown effectiveness of these drugs for treatment of late-age declines while others have failed to show any effect. Conflicting results between studies can potentially be explained by genetic differences among individuals. The primary goal of this research was to develop methods to measure physical performance with age and identify, via genome-wide association (GWA) and follow-up functional genetic studies, genes associated with physical ability at late age and those that contribute to differences among genotypes in the phenotypic response (climbing speed and endurance) to Lisinopril. I used Drosophila melanogaster as a model system and the Drosophila Genetic Reference Panel (DGRP) for GWA mapping. The second goal was to map climbing speed and endurance in untreated and Lisinopril-treated flies. This revealed genetic pathways that are acted on by this drug and polymorphisms that altered individual responses to the drug. My results have contributed to our understanding of the genetic bases of natural variation in physical performance at older ages. Many of the genes identified this study have human orthologs. As a result, my findings have laid the groundwork for designing personalized medical applications to treat age-related declines in physical performance and provide novel genetic targets for pharmaceutical development to extend health span in older adults.
dc.formatapplication:pdf
dc.genredissertations
dc.identifierdoi:10.13016/m2aoyu-0pbr
dc.identifier.other11914
dc.identifier.urihttp://hdl.handle.net/11603/20908
dc.languageen
dc.relation.isAvailableAtThe University of Maryland, Baltimore County (UMBC)
dc.relation.ispartofUMBC Biological Sciences Department Collection
dc.relation.ispartofUMBC Theses and Dissertations Collection
dc.relation.ispartofUMBC Graduate School Collection
dc.relation.ispartofUMBC Student Collection
dc.sourceOriginal File Name: Gabrawy_umbc_0434D_11914.pdf
dc.subjectAging
dc.subjectDrosophila
dc.subjectGenetics
dc.subjectLisinopril
dc.subjectPhysical performance
dc.titleIdentification of Genetic Variants Influencing Efficacy of Lisinopril Treatment on Age-specific Physical Performance: A Genome-wide Analysis in Drosophila melanogaster
dc.typeText
dcterms.accessRightsDistribution Rights granted to UMBC by the author.
dcterms.accessRightsAccess limited to the UMBC community. Item may possibly be obtained via Interlibrary Loan thorugh a local library, pending author/copyright holder's permission.
dcterms.accessRightsThis item is likely protected under Title 17 of the U.S. Copyright Law. Unless on a Creative Commons license, for uses protected by Copyright Law, contact the copyright holder or the author.

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Gabrawy_umbc_0434D_11914.pdf
Size:
4.64 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
GabrawyMIdentification_Open.pdf
Size:
51 KB
Format:
Adobe Portable Document Format
Description: